Education
About Us
Working with TipRanks
Follow Us
Helius Medical Technologies (HSDT)
NASDAQ:HSDT
Total Valuation
Helius Medical Technologies has a market cap or net worth of $1.85M. The enterprise value is $1.42M.
Market Cap$1.85M
Enterprise Value$1.42M
Share Statistics
Helius Medical Technologies has 6.13M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6.13M
Owened by Insiders6.85%
Owened by Instutions1.48%
Financial Efficiency
Helius Medical Technologies’s return on equity (ROE) is -11.09 and return on invested capital (ROIC) is -1017.04%.
Return on Equity (ROE)-1108.78%
Return on Assets (ROA)-331.51%
Return on Invested Capital (ROIC)-1017.04%
Return on Capital Employed (ROCE)-1008.19%
Revenue Per Employee$23,904.762
Profits Per Employee-$421,857.095
Employee Count21
Asset Turnover0.15
Inventory Turnover0.56
Valuation Ratios
The current PE Ratio of Helius Medical Technologies is -1.55. Helius Medical Technologies’s PEG ratio is 0.02.
PE Ratio-1.55
PS Ratio34.93
PB Ratio17.15
Price to Fair Value17.15
Price to FCF-1.64
Price to Operating Cash Flow-1.65
PEG Ratio0.02
Income Statement
In the last 12 months, Helius Medical Technologies had revenue of $502.00K and earned -$8.86M in profits. Earnings per share was -$6.18.
Revenue$502.00K
Gross Profit-$31.00K
Operating Income-$13.00M
Pretax Income-$8.86M
Net Income-$8.86M
EBITDA-12.95M
Earnings Per Share (EPS)-6.18
Cash Flow
In the last 12 months, operating cash flow was -$10.70M and capital expenditures -$8.00K, giving a free cash flow of -$10.70M billion.
Operating Cash Flow-$10.70M
Free Cash Flow-$10.70M
Free Cash Flow per Share-$1.75
Dividends & Yields
Helius Medical Technologies pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-60.81%
Earnings Yield-64.65%
Stock Price Statistics
Beta0.09
52-Week Price Change-94.85%
50-Day Moving Average0.47
200-Day Moving Average0.63
Relative Strength Index (RSI)42.65
Average Volume (3m)126.39K
Important Dates
Helius Medical Technologies upcoming earnings date is May 8, 2025, After Close.
Last Earnings DateMar 13, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Helius Medical Technologies as a current ratio of 1.58, with Debt / Equity ratio of 0.01
Current Ratio1.58
Quick Ratio1.10
Debt to Market Cap<0.01
Net Debt to EBITDA0.08
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Helius Medical Technologies has paid -$27.28K in taxes.
Income Tax-$27.28K
Effective Tax Rate0.00%
Enterprise Valuation
Helius Medical Technologies EV to EBITDA ratio is -1.23, with an EV/FCF ratio of -1.55.
EV to Sales32.86
EV to EBITDA-1.23
EV to Free Cash Flow-1.55
EV to Operating Cash Flow-1.55
Balance Sheet
Helius Medical Technologies has $3.47M in cash and marketable securities with $23.00K in debt, giving a net cash position of -$3.44M billion.
Cash & Marketable Securities$3.47M
Total Debt$23.00K
Net Cash-$3.44M
Net Cash Per Share-$0.56
Tangible Book Value Per Share$0.04
Margins
Gross margin is -11.92%, with operating margin of -2673.65%, and net profit margin of -2258.08%.
Gross Margin-11.92%
Operating Margin-2673.65%
Pretax Margin-2258.08%
Net Profit Margin-2258.08%
EBITDA Margin-2673.65%
EBIT Margin-2665.96%
Analyst Forecast
The average price target for Helius Medical Technologies is , which is 11.43% higher than the current price. The consensus rating is Hold
Price Target
Price Target Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-19.25%
EPS Growth Forecast59.74%